Vimarsana
Biggest News Aggregation in the World

Director Vidal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Vidal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Vidal Today - Breaking & Trending Today

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers - Vimarsana News

Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers

On May 28, a group of five former Directors, Deputy Directors and Patent Commissioners at the U.S. Patent and Trademark Office (USPTO) sent a letter addressed to current USPTO Director Kathi Vidal in opposition to a rule package on terminal disclaimer practice proposed earlier this month.

Israeli Patent Attorneys Urge Vidal to Reassign Reddit Examiner's Application - Vimarsana News

Israeli Patent Attorneys Urge Vidal to Reassign Reddit Examiner's Application

Representatives of intellectual property provisional organizations in Israel recently wrote to USPTO Director Kathi Vidal to voice concerns relating to the anonymous examiner who several weeks ago took to Reddit to discuss examining the patent application of an unidentified Israeli defense contractor.

Other Barks & Bites for Friday, April 12: Bill to Rein in GAI Introduced; Amazon Owes Tech Rival $525 Million for Patent Infringement; USPTO Issues Guidance on the Use of AI for Filings - Vimarsana News

Other Barks & Bites for Friday, April 12: Bill to Rein in GAI Introduced; Amazon Owes Tech Rival $525 Million for Patent Infringement; USPTO Issues Guidance on the Use of AI for Filings

This week in Other Barks & Bites: three advocacy groups call on President Biden’s administration to use federal law to license the production and cut the price of an expensive cancer drug; an Illinois jury rules that Amazon owes Kove IO $525 million in a patent infringement case; and more.

Issue 44: PTAB Trial Tracker | Goodwin - Vimarsana News

Issue 44: PTAB Trial Tracker | Goodwin

The availability of post-grant proceedings at the Patent Trial and Appeal Board (PTAB) has changed the face of patent litigation. This periodic digest is designed to keep you up-to-date...

Vidal Delays OpenSky Payment But Upholds Attorney's Fees Award for VLSI - Vimarsana News

Vidal Delays OpenSky Payment But Upholds Attorney's Fees Award for VLSI

On March 11, U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal issued an order on rehearing that upheld the attorney’s fees award levied against petitioner OpenSky Industries over its abuse of process during inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB).